Modulation of endogenous prostaglandins by thymosin-alpha 1 in lymphocytes.
Rinaldi-Garaci. C C; Garaci. E E; Del Gobbo. V V; Favalli. C C; Jezzi. T T; Goldstein. A L AL
Key Findings
- Thymosin‑alpha‑1 both stimulates and inhibits PGE2 release from lymphocytes depending on the mouse’s thymus status.
- In thymectomized mice, the peptide restores sensitivity to the drug azathioprine, linking it to immune regulation.
- Peak blood activity of thymosin‑alpha‑1 occurs at ~1 hour, whereas maximal downstream immune (FTS‑like) activity is seen after ~24 hours, and this process is blocked by the prostaglandin inhibitor indomethacin.
Practical Outcomes
- For biohackers, the data suggest thymosin‑alpha‑1 may modulate inflammation and immune drug responses, but the effects are context‑dependent and observed only in mice. No clear human dosing or protocol emerges, so any experimentation should be cautious and consider that the peptide’s immune actions rely on prostaglandin pathways.
Summary
The study shows that thymosin‑alpha‑1 can change how immune cells make the inflammation‑related molecule PGE2, but its effects differ between normal mice and those lacking a thymus. The peptide’s activity peaks quickly in the blood, while downstream immune changes take a day to appear, and these changes need prostaglandin production to happen.
Abstract
The effects of thymosin-alpha 1 on the stimulation of specific release of prostaglandin E2 (PGE2) from splenic lymphocytes and thymocytes were studied. Experiments were also performed to study in parallel the absolute levels of thymosin-alpha 1 in the blood and the induction of serum FTS activity and of azathioprine sensitivity of spleen cells from adult thymectomized (ATx) mice. A significant difference in the release of PGE2 between normal splenocytes and splenocytes from ATx mice was observed. Thymosin-alpha 1 at certain concentrations was able to stimulate PGE2 release from lymphocytes of ATx mice while inhibiting release in lymphocytes of normal mice. Also, thymocytes were stimulated to release PGE2 after incubation with alpha 1 in a manner similar to that seen in spleen cells of ATx mice. Approximately the same concentrations of alpha 1 was found to also correct the low azathioprine sensitivity of splenocytes from ATx mice. Determinations of FTS-like activity in the blood and the pharmacokinetics of alpha 1 after administration of this synthetic molecule show a clear dissociation. A maximum peak of alpha 1 activity was obtained after 1 hr, while maximal FTS-like activity was observed after 24 hr. The inhibition of the induction by alpha 1 of FTS-like activity and of Thy 1.2 antigen by indomethacin suggests that the action of alpha 1 requires prostaglandin biosynthesis.
Study Information
pubmed
1983
10.1016/0008-8749(83)90093-x